Dermatology: Fillers, Neurotoxins, and Chemical Peels

, Julie Karen1 and Perry Robins1



(1)
New York University School of Medicine, New York, NY, USA

 






Table 4.1
Botulinum toxin dilutions
































Amount of saline used for dilution (mL)
Units of Botox® per 0.1 cc (U)
Common indications

1
10
  

2
5
Facial rhytides

2.5
4
Facial rhytides

4
2.5
Axillary hyperhidrosis (usual dose 100 U)

5
2
Axillary hyperhidrosis


Notes:

• Mechanism of action: inhibits acetylcholine (ACh) release by cleaving proteins in the SNARE complex required for ACh release

• Dilution should be performed with 0.9 % normal saline

• One unit of Botox® is approximately equivalent to 2.5–3 units of Dysport® (abobotulinum toxin A)

• One unit of Botox® is approximately equivalent to 1 unit of Xeomin® (incobotulinum toxin A)



Table 4.2
Injectable fillers


























Filler
Duration
Derivation
Comments

Alloderm®

Months to years
Acellular human cadaveric dermis
Surgically implanted in sterile filed

Artecoll®a,  Artefil®

Permanent (>5 years)
PMMAb beads in bovine collagen, allergy test required
Injected deeper than collagen

LaViv®a

Only gold members can continue reading. Log In or Register to continue

Related posts:

Default ThumbnailVeins Default Thumbnailand Other Technology Repairs Anatomy and Non-excisional Surgery Ichthyoses

Stay updated, free articles. Join our Telegram channel
Tags:
Apr 1, 2017 | Posted by in Dermatology | Comments Off on Dermatology: Fillers, Neurotoxins, and Chemical Peels

Full access? Get Clinical Tree

 Get Clinical Tree app for offline access